Home
Research Trends
Papers list
Open Access Journals
All Journals
Search in Journals
Contact us
Sign Up
Login
Journal of Nuclear Medicine
Title
Publication Date
Language
Citations
Prognostic Value of18F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study
2023/11/09
English
Characterizing Normal Variant [68Ga]Ga-FAPI-46 Uptake in the Epididymis
2023/11/09
English
61Cu-Labeled Radiotracers: Alternative or Choice?
2023/10/26
English
Artificial Intelligence Predicts Hospitalization for Acute Heart Failure Exacerbation in Patients Undergoing Myocardial Perfusion Imaging
2024/03/28
English
SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [177Lu]Lu-DOTATATE
2024/03/28
English
High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET
2024/03/28
English
Cancer Risk in Graves Disease with Radioactive131I Treatment: A Nationwide Cohort Study
2024/03/28
English
18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer
2024/03/21
English
Gerald L. DeNardo, MD, 1932–2024
2024/03/21
English
Impact of18F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning–Generated Biomarkers
2024/03/21
English
Preclinical Characterization of DPI-4452: A68Ga/177Lu Theranostic Ligand for Carbonic Anhydrase IX
2024/03/21
English
Effectiveness and Safety of Retreatment with177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States
2024/03/21
English
Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses
2024/03/21
English
Quantitative Brain Amyloid PET
2024/03/21
English
Interrogating the Theranostic Capacity of a MUC16-Targeted Antibody for Ovarian Cancer
2024/03/14
English
68Ga-FAPI PET/CT as an Alternative to18F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma
2024/03/14
English
Human Epidermal Growth Factor Receptor 2 (HER2) PET Imaging of HER2-Low Breast Cancer with [68Ga]Ga-ABY-025: Results from a Pilot Study
2024/03/28
English
Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis
2024/03/28
English
Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?
2024/03/28
English
An18F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non–Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy
2024/03/14
English
Real-World Experience with177Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval
2024/03/14
English
Strong Correlation Between SUVmaxon PSMA PET/CT and Numeric Drop-In γ-Probe Signal for Intraoperative Identification of Prostate Cancer Lesions
2024/03/14
English
Efficacy of [67Cu]Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2–Positive Neuroendocrine Tumors
2024/03/14
English
The Value of68Ga-PSMA PET/MRI for Classifying Patients with PI-RADS 3 Lesions on Multiparametric MRI: A Prospective Single-Center Study
2024/03/14
English
[18F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases
2024/03/14
English
64Cu-DOTA Enables Late PET Imaging and Leak Detection in the Cerebrospinal Fluid Space
2024/03/14
English
Example of Artificial Intelligence–Based Decision Support for Amino Acid PET: Early Prediction of Suspected Brain Tumor Foci for Patient Management
2024/02/15
English
Looking at the Future of Prostate Cancer Treatment
2023/04/13
English
Imaging of Tumor Stroma Using68Ga-FAPI PET/CT to Improve Diagnostic Accuracy of Primary Tumors in Head and Neck Cancer of Unknown Primary: A Comparative Imaging Trial
2024/01/25
English
First-in-Human Evaluation of Site-Specifically Labeled89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer
2024/01/25
English
«
‹ Pervious
Next ›
»